在患有血液性恶性瘤的患者中验证FACT-G7
Xinwen Du1, Ling Mao1, Yamei Leng1
1Department of Hematology, West China Hospital/West China School of Nursing, Sichuan University, Chengdu, China.
Frontiers in oncology
|August 28, 2023
概括
中国版的7项功能评估癌症治疗一般 (FACT-G7) 是一个有效的工具,用于评估中国患者血液恶性瘤的生活质量. 这个简短的措施有助于评估治疗效果和预后.
科学领域:
- 在瘤学瘤学.
- 健康 结果 研究 研究 结果
- 心理测量 心理测量 心理测量
背景情况:
- 对患有血液性恶性瘤的患者来说,评估生活质量至关重要,反映治疗疗效和预后.
- 长时间的生命质量评估对患者来说可能是负担.
- 癌症治疗一般的7项功能评估 (FACT-G7) 提供了一种简短,快速的方法来评估生活质量.
研究的目的:
- 验证FACT-G7的中文版本,用于评估诊断为血液性恶性瘤的中国患者的生活质量.
主要方法:
- 一项涉及855名患有血液性恶性瘤的患者的横截面研究.
- 使用了克朗巴赫的α,确认因素分析,皮尔森的相关性和单向ANOVA.
- 评估了与FACT-G和ECOG-PS相比的内部一致性,结构有效性和并发有效性.
主要成果:
- 中国的FACT-G7表现出可以接受的内部一致性 (克朗巴赫的α=0.73).
- 确认性因子分析表明近乎充分的模型适合单个因子结构.
- 满意的相关性证实了与FACT-G和ECOG-PS的并发有效性.
结论:
- 中国版本的FACT-G7是一个有用和快速的工具,用于评估血液恶性瘤的中国患者的生活质量.
- 为进一步的临床评估和患者护理提供了宝贵的参考资料.
- 支持在瘤学环境中使用简短,经过验证的仪器.
更多相关视频
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.4K
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
7.9K
相关概念视频
Bone Marrow Sampling and Transplants
359
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
359
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
